arrow
J

Jongmin Sim

korea university anam hospital
H指数:15
被引数:701

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)

厄洛替尼联合贝伐珠单抗治疗EGFR扩增的转移性实体瘤患者:KOSMOS-II(基于基因组改变在晚期实体瘤中进行分子分型指导治疗的韩国精准医学网络研究组研究,KCSG AL 22-09)的结果

2024-12-010
PRE
Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors

表达间变性淋巴瘤激酶 (ALK) 的肺腺癌合并神经内分泌成分或神经内分泌转化: 对神经内分泌转化和ALK-酪氨酸激酶抑制剂反应的影响

2018-01-015
OAAI